Improving accessibility of advanced molecular diagnostics in precision oncology
Liquid biopsy genetic tests are making precision cancer diagnostics simpler and quicker than ever before. Using a blood...
Awards shine a light on post-pandemic healthcare innovation
Sagentia Innovation’s Rob Morgan and Paulo Pinheiro helped judge the Cambridge Independent Science and Technology...
Webinar: What’s next in women’s health?
The last five years have seen a significant increase in women’s health research and investment. Emerging technologies...
Making at-home-molecular tests affordable, actionable and sustainable
Taking diagnostic testing to patients’ homes offers many advantages for global healthcare, and progress in molecular...
Breaking the mould in microplastics
Microplastics can be found wherever we choose to look, from remote Arctic locations to marine organisms and the air we...
When should you contact FDA about a new medical device?
Medical device companies often ask us about the best time to contact FDA for regulatory guidance. There’s a delicate...
Answering C-Suite top level R&D questions to accelerate and de-risk innovation – find out how our experts deliver answers to the big questions
Sagentia Innovation’s advisory team handles big questions like these on a daily basis. Our clients’ environments...
Mixed Reality and healthcare: a new frontier
Mixed reality (MR) is currently the darling of immersive technology. It combines all the benefits of augmented reality...
Data Strategies for Connected Health
The race is on to develop healthcare solutions which harness the enormous capabilities of sensor and communication...
Six steps to obtaining 510(k) premarket clearance for medical devices
Companies that think about regulatory strategy in the early stages of medical device development can benefit from...
